1Pfister R,Tan D,Thekkanal J,et al.Predictors of elevated NT-pro-BNP in cardiovascular patients without acute heart failure.Int J Cardiol,2009,131:277-280.
2Choi SY,Lee JE,Jang EH.et al.Association between changes in N-terminal pro-brain natriuretic peptide levels and changes in left ventricular mass index in stable hemodialysis patients.Nephron Clin Pract,2008,110:c93-cl00.
3Olsen MH,Hansen TW,Christensen MK,et al.Cardiovascular risk prediction by N-terminal pro-brain natriuretic peptide and high sensitivity C-reactive protein is affected by age and sex.J Hypertens,2008,26:26-34.
4Abraham WT,Lowes BD,Ferguson DA,et al.Systemic hemodynamic,neurohormonal,and renal excretory effects of a steady-state infusion of human brain natriuretic peptide in patients with decompensated chronic heart failure.J Card Fail,1998,4:37-44.
5Mills RM,LeJemtel TH,Horton DP,et al.Sustained hemodynamic effects of an infusion of nesiritide (human b-type natriuretic peptide) in heart failure:a randomized,double-blind,placebo-controlled clinical trial.Natrecor Study Group.J Am Coll Cardiol,1999,34:155-162.
6Colucci WS,Elkayam E,Horton DP,et al.Intravenous nesiritide,a natriuretic peptide,in the treatment of decompensated heart failure.N Engl J Med,2000,343:246-253.
7Kawakami R,Saito Y,Kishimoto I,et al.Overexpression of brain natriuretic peptide facilitates neutrophil infiltration and cardiac matrix metalloproteinase-9 expression after acute myocardial infarction.Circulation,2004,110:3306-3312.
8Keating GM,Goa KL.Nesiritide:a review of its use in acute decompensated heart failure.Drugs,2003,63:47-70.
9de Lemos JA,McGuire DK,Drazner MH.B-type natriuretic peptide in cardiovascular disease.Lancet,2003,362:316-322.
10Strain WD.The use of recombinant human B-type natriuretic peptide (nesiritide) in the management of acute decompensated heart failure.Int J Clin Pract,2004,58:1081-1087.
